Acute Asthma Exacerbation Management
A 5 year old boy with known asthma presents with worsening wheeze and breathlessness. Respiratory rate is 44 breaths/min and oxygen saturation 92 percent in room air, with subcostal and intercostal retractions and widespread expiratory wheeze. He speaks in short phrases. After 3 back to back nebulised salbutamol and ipratropium treatments over 1 hour he remains tachypneic and wheezy. Which is the most appropriate next step in management?
- A.Inhaled long acting beta 2 agonist
- B.Inhaled corticosteroid
- C.Intravenous aminophylline
- D.Systemic corticosteroidCorrect
Explanation
A moderate to severe asthma exacerbation that does not settle after repeated inhaled bronchodilators requires systemic corticosteroid, given orally as prednisolone 1 to 2 mg/kg or intravenously as methylprednisolone if the child cannot tolerate oral therapy. Corticosteroids suppress the late phase eosinophilic inflammation and mucosal edema that bronchodilators cannot reverse, upregulate beta 2 receptors to restore responsiveness to salbutamol, shorten the exacerbation, reduce admission rates and prevent early relapse. Clinical benefit begins within 2 to 4 hours, which is why the dose should be given early rather than held back, and a 3 to 5 day course without tapering is sufficient in children. Inhaled corticosteroids are controller therapy and do not deliver adequate drug to inflamed, obstructed airways during an acute severe attack, so they cannot replace systemic steroid at this point. Aminophylline has a narrow therapeutic index with vomiting, arrhythmias and seizures, and is reserved for critically ill children in intensive care who have failed maximal inhaled therapy, systemic steroid and magnesium sulfate. Long acting beta 2 agonists have no role in the acute setting; salmeterol in particular has too slow an onset. Adjuncts in refractory cases include intravenous magnesium sulfate, continuous nebulised salbutamol, and escalation to high flow oxygen or intensive care if the child is exhausted, hypoxemic or acidotic. A rising or normal PaCO2 in a tachypneic asthmatic child is an ominous sign of impending respiratory failure.
Why each option
- A.
- Long acting beta 2 agonists are maintenance therapy and have no established role in the acute emergency management of an exacerbation.
- B.
- Inhaled corticosteroid does not penetrate obstructed airways adequately during an acute attack and is not a substitute for systemic steroid.
- C.
- Aminophylline is toxic and reserved for intensive care management of refractory life threatening asthma after steroids and magnesium have failed.
- D.
- Correct. Systemic corticosteroid is indicated for any exacerbation failing to respond promptly to inhaled bronchodilators; it treats the inflammatory component and restores beta 2 receptor responsiveness.
Reference: GINA Global Strategy for Asthma Management and Prevention, 2024
This is one of 3,306 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank